Inovia Bio
Accelerating drug development with AI and big data
- 1-20 employees
- Healthcare
- B2B
- Deep Tech
- Biotechnology
- Canary Wharf, London, UK
Jump to section
Company mission
To revolutionise drug development.
Our take
Inovia Bio is helping drug developers navigate the entire development process, from early-stage evaluation to regulatory approval. By providing evidence-based predictions and real-time data, teams can make faster, more informed decisions and uncover opportunities.
With tools like InovaLandscape, InovaMine, and InovaIEP, Inovia Bio streamlines critical tasks like analysing competitive landscapes in real-time, speeding up returns on Real World Evidence, and ensuring alignment across teams. Inovia Bio gives drug developers the insights and efficiency they need to make smarter, faster decisions, driving progress with precision.
Freddie
Company Specialist at Welcome to the Jungle
Leadership
Antonio Nicolae
(Co-Founder & CTO)Prior to co-founding Inovia Bio in 2022, they were they Head of Data at Unilever. They also worked as a Data Engineer at Curve and Nested Estate Agents and as a Software Engineer at Weengs.
Imi F.
(Co-Founder & Chief Scientific and Business Officer)Previously a Senior Director of Early Phase Oncology at Gilead Sciences, a Director of Medical Affairs Oncology at Kite Pharma, and a Senior Scientist (PHC Oncology) at Roche.